A feasibility study on quantitating myocardial perfusion with Albunex, an ultrasonic contrast agent

Advanced spectral analyses for real-time automatic echographic tissue-typing of simulated tumor masses at different compression stages

Prototypal software algorithms for advanced spectral analysis of echographic images were developed to perform automatic detection of simulated tumor masses at two different pathological stages. Previously published works documented the possibility of characterizing macroscopic variation of mechanical properties of tissues through elastographic techniques, using different imaging modalities, including ultrasound (US); however, the accuracy of US-based elastography remains affected by the variable manual modality of the applied compression and several attempts are under investigation to overcome this limitation. Quantitative US (QUS), such as Fourier- and wavelet-based analyses of the RF signal associated with the US images, has been developed to perform a microscopic-scale tissue-type imaging offering new solutions for operator-independent examinations. Because materials able to reproduce the harmonic behavior of human liver can be realized, in this study, tissue-mimicking structures were US imaged and the related RF signals were analyzed using wavelet transform through an in-house-developed algorithm for tissue characterization. The classification performance and reliability of the procedure were evaluated on two different tumor stiffnesses (40 and 130 kPa) and with two different applied compression levels (0 and 3.5 N). Our results demonstrated that spectral components associated with different levels of tissue stiffness within the medium exist and can be mapped onto the original US images independently of the applied compressive forces. This wavelet-based analysis was able to identify different tissue stiffness with satisfactory average sensitivity and specificity: respectively, 72.01% ± 1.70% and 81.28% ± 2.02%.

Experimental investigation and theoretical modelling of the nonlinear acoustical behaviour of a liver tissue and comparison with a tissue mimicking hydrogel

Native harmonics generated by nonlinear distortion of ultrasound during propagation in a medium may cause misinterpretations in spectral analysis when studying contrast agents. The aim of this paper is to quantitatively evaluate nonlinear propagation effects of diagnostic ultrasound pulses in biological tissues and to assess whether a cellulose-based hydrogel can be a suitable material for tissue mimicking purposes. Hydrogel and pig liver tissue samples of various thicknesses were insonified in a through-transmission set-up, employing 2.25-MHz pulses with different mechanical index (MI) values (range 0.06-0.60). Second harmonic and first harmonic amplitudes were extracted from spectra of received signals and their ratio was then used to compare hydrogel and liver behaviours. Resulting trends are very similar for sample thicknesses up to 8 cm and highlight a significant increase in nonlinearity for MI > 0.3, for both liver and hydrogel. A numerical procedure was also employed to calculate pressure distribution along the beam axis: these theoretical results showed a very good agreement with experimental data in the low pressure range, though failed in predicting the MI threshold. In conclusion, the hydrogel resulted to be a suitable material for manufacturing tissue mimicking phantoms, in particular to study contrast agent behaviour with a "low power approach".

Estimation of forward and backward mitral flow using indicator dilution technique: a theoretical feasibility study

A new theoretical algorithm is presented for high-resolution mitral flow determination based on the indicator dilution principle. The algorithm allows forward as well as backward time-dependent mitral flow estimation with a beat-to-beat resolution. Indices of normal/subnormal left heart functioning, including total stroke volume (TSV), cardiac output (CO), total ejection fraction (TEF), mitral regurgitation volume (MRV) and mitral regurgitation fraction (MRF), are determined. Knowledge of left atrium and ventricle indicator concentration versus time dependencies and the end systolic left atrium and ventricle volumes are sufficient to determine the mitral flow pattern. However, the non-dimensional index of the total ejection fraction can be calculated on the basis of only the indicator concentration. The algorithm was validated by applying it to blood flows and heart chamber volumes derived from a computer simulation of the cardiovascular circulation. First left heart concentrations versus time data were obtained by determining the distribution over a cardiovascular tract of an ideal indicator, a bolus of which was intravenously injected into one of the arms. Then the backward problem of finding mitral flow was solved. The accuracy of the mitral flow estimation depends on the accuracy of end systolic left atrium and ventricle volume data. The method is applicable over a wide range of aortic regurgitation, up to 20% of cardiac output, suggesting that the algorithm might become a robust technique of non-invasive mitral flow assessment, replacing traditional techniques such as nuclear radiography.

Transfer function analysis of ultrasonic time-intensity measurements

Time-intensity measurements of ultrasonic-contrast microbubbles based on the dilution theory have been used to assist blood flow estimation. The compartment model has been employed to describe the dilution process. Under the linear and time-invariant assumption, the time-intensity curve measured at the output of a compartment (i.e., blood mixing chamber) is the convolution of the input time-intensity curve with the compartment's transfer function. Thus, transfer function analysis is possible using deconvolution when the temporal variations in both the input and the output intensities are available. Note that the linear and time-invariant assumption requires a constant flow rate because, with flow pulsation, the flow rate changes with time and the mixing process becomes time varying. Thus, the purpose of this paper was to study the effects of flow pulsation on time-intensity measurements. In addition, a deconvolution technique based on a recursive least squares approach is used for transfer function analysis. Both simulations and experiments were performed; the results from which indicate that the pulsation generally does not affect the validity of time-intensity-based flow estimation. The proposed deconvolution technique is also effective for both constant and pulsatile flows; thus, permitting transfer function analysis in various flow conditions. One potential application of this transfer function analysis is to remove the effects of a noninstantaneous input function. The results from this paper lead to future work in brain-perfusion estimation based on extracranial time-intensity measurements.

Targeted imaging using ultrasound

The discipline of medical imaging is expanding to include both traditional anatomic modalities and new techniques for the functional assessment of the presence and extent of disease. Current FDA-approved ultrasound contrast agents are micron-sized bubbles with a stabilizing shell. Microbubble contrast agents can be used to estimate microvascular flow rate in a manner similar to dynamic contrast-enhanced magnetic resonance imaging (MRI). The concentration of these agents within the vasculature, reticulo-endothelial, or lymphatic systems produces an effective passive targeting of these areas. Liquid-filled nanoparticles and liposomes have also demonstrated echogenicity and are under evaluation as ultrasound contrast agents. Actively targeted ultrasound relies on specially designed contrast agents to localize the targeted molecular signature or physiologic system. These agents typically remain within the vascular space, and therefore possible targets include molecular markers on thrombus, endothelial cells, and leukocytes. The purpose of this review is to summarize the requirements, challenges, current progress, and future directions of targeted imaging with ultrasound.

Time-intensity-based volumetric flow measurements: an in vitro study

Ultrasonic contrast agents have been used to assist blood flow measurements. Several contrast-specific flow measurement techniques have been proposed during the last few years. Among them, a method based on relative enhancement of the backscattered signal as a function of time is of particular interest. This method is also known as the time-intensity method. The method is based on the indicator-dilution theory, and the time-intensity curve is used to derive blood flow-related parameters such as the flow rate and the blood mixing volume. Previous in vitro studies done by other research groups were mainly based on a perfusion model or an artery model. Results showed that several parameters derived from the time-intensity curve had a good correlation with the flow rate under certain conditions. However, the studies did not focus on factors such as mixing volume, mixing chamber configuration and different types of mixing chamber. In this paper, dependence of the time-intensity curve is further studied. Specifically, two types of blood-mixing chambers were constructed. One was a spherical compartment phantom with two different sizes (260 and 580 mL) and different inflow/outflow configurations. The other was a perfusion phantom consisting of dialysis cartridges with the volume ranging from 114 to 351 mL. The time intensities were also measured at both the input and the output of the mixing chamber. A commercial agent (Levovist) and a self-made, albumin-based agent were used and the wash-out time constant and the mean transit time were derived for flow rates ranging from 500 to 1300 mL/min. For the perfusion phantom, results showed that the parameters had a good correlation with both the flow rate and the mixing volume. Results from the compartment phantom, on the other hand, indicated that the inflow/outflow configuration and the mixing size significantly affected the derived time constants. Potential applications of new volumetric flow estimation techniques based on both input and output intensities were also discussed.

Feasibility study of time-intensity-based blood flow measurements using deconvolution

Ultrasonic contrast agents have been used to enhance the acoustic backscattered intensity of blood and to assist the assessment of blood flow parameters. One example is the time-intensity method based on the indicator-dilution theory. In this case, a mixing chamber model can be employed to describe the concentration of the contrast agent as a function of time. By measuring the time intensities at both the input and output of the blood mixing chamber, blood flow information can be obtained if proper deconvolution techniques are applied. Note that most deconvolution techniques assume a linear and time invariant (LTI) system for the mixing of the contrast agent with blood. In this paper, the hypothesis that a blood mixing chamber is an LTI system was tested. Several aspects were studied. One aspect was the linear relationship between the concentration of the contrast agent and the backscattered intensity. The other aspect was the dependence of the derived time constants on the concentration. The concept of an effective mixing volume was also introduced and evaluated. Finally, the input and the output time constants were measured and compared to theory under the LTI assumption. Extensive experiments were performed. Two in vitro flow models were constructed and two contrast agents were used. Results indicated that the LTI assumption does not hold and quantitative flow estimation is generally not possible. Nonetheless, the indicator-dilution theory can still be applied if only relative measurements of the flow rate are required.

High-resolution functional imaging with ultrasound contrast agents based on RF processing in an in vivo kidney experiment

Knowledge of the relative tissue perfusion distribution is valuable in the diagnosis of numerous diseases. Techniques for the assessment of the relative perfusion distribution, based on ultrasound (US) contrast agents, have several advantages compared to established nuclear techniques. These are, among others, a better spatial and temporal resolution, the lack of exposure of the patient to ionizing radiation and the relatively low cost. In the present study, US radiofrequency (RF) image sequences are acquired, containing the signal intensity changes associated with the transit of a bolus contrast agent through the microvasculature of a dog kidney. The primary objective is to explore the feasibility of calculating functional images with high spatial resolution. The functional images characterize the transit of the contrast agent bolus and represent distributions of peak time, peak value, transit time, peak area, wash-in rate and wash-out decay constant. For the evaluation of the method, dog experiments were performed under optimized conditions where motion artefacts were minimized and an IA injection of the contrast agent Levovist was employed. It was demonstrated that processing of RF signals obtained with a 3.5-MHz echo system can provide functional images with a high spatial resolution of 2 mm in axial resolution, 2 to 5 mm in lateral resolution and a slice thickness of 2 mm. The functional images expose several known aspects of kidney perfusion, like perfusion heterogeneity of the kidney cortex and a different peripheral cortical perfusion compared to the inner cortex. Based on the findings of the present study, and given the results of complimentary studies, it is likely that the functional images reflect the relative perfusion distribution of the kidney.

Study on the lifetime and attenuation properties of microbubbles coated with carboxylic acid salts

Four kinds of surfactants, sodium laurate, sodium myristate, sodium palmitate and sodium oleate were used to study the effects of surfactant coatings on the lifetime and attenuation of microbubbles. The changes in the size distribution of microbubbles prepared with these surfactants in saline were measured with a Coulter Multisizer (Coulter Electronics Ltd., Luton, UK). Frequency characteristics of ultrasonic attenuation of the microbubble suspensions were measured between 400 kHz and 6 MHz. From the changes in attenuation in the microbubble suspensions over time, it was found that the lifetime of microbubbles in a suspension also depends on the frequency of the irradiating ultrasound. The effect of surfactants on the frequency characteristics of attenuation was also studied, and characteristics of the surfactant coating, including shell elasticity and shell friction parameters were calculated from the measurement results. Microbubbles produced with sodium palmitate had the longest lifetime and the smallest average size. The shell had very little effect on the ultrasonic properties of microbubbles produced with sodium palmitate, suggesting that the sodium palmitate microbubbles behaved ultrasonically as free microbubbles.

An in vitro comparison of ultrasonic contrast agents in solutions with varying air levels

The performance, in particular, the stability of ultrasound (US) contrast agents has yet to be assessed. An in vitro system has been set up to investigate the properties of ultrasonic contrast agents under different suspension conditions. This is designed to contribute to the optimal use of agents in clinical practice. In this study, the contrast agents were introduced into solutions of different oxygen concentration levels, as might be encountered in blood, and their relative performance was assessed in terms of decay in the solution environment. The partial pressures of oxygen in those solutions ranged between 1.5 and 26 kPa. Three IV and one arterial contrast agents were used: Levovist, DMP115, Quantison and Myomap. Levovist showed the highest sensitivity to oxygen concentration in the solution, and the other three proved tolerant for the above values of oxygen concentrations.

Feasibility of mitral flow assessment by echo-contrast ultrasound, part I: determination of the properties of echo-contrast agents

Data on the ultrasonic properties of commercially available contrast agents are limited by being instrument-dependent, especially with regard to their backscattering properties. The present work describes methods of measurements that provide instrument-independent estimations of a contrast agent's attenuation coefficient and integrated backscatter index and provide them as functions of its concentration. The two studied commercially available contrast agents were Albunex and Levovist SHU 508-A, both representative of agents in common use for echocardiography. The attenuation coefficients and integrated backscatter indices of both agents were found to be a linear function of their concentrations. Proportionality coefficients +/- their standard deviations are provided. Actually, square root values of the averaged backscatter indices normalized with respect to the rms of the reference signal were determined. The coefficients of proportionality were found to be: C(A) = 3.11+/-0.1813 dB/mm; C(L) = 0.07+/-0.005 dB/mm for attenuation coefficients of the Albunex and Levovist contrast agents, respectively, and the corresponding values for backscattering were: D(A) = 0.07+/-0.0054; D(L) = 0.02+/-0.0012. Being apparatus-independent, the findings of the study are important prerequisites for the use of these echo-contrast agents as an indicator in research for a quantitative assessment of blood flow.

Feasibility of mitral flow assessment by echo-contrast ultrasound, part II: experimental study on a mechanical model of the left heart

The feasibility of assessing mitral flow by means of ultrasonic monitoring of backscattered power from an echo-contrast agent in the left atrium and left ventricle was studied. A mechanical model of the left heart was built in which two thin rubber balloons connected to each other in a feedback loop via two artificial heart valves mimicked the left atrium and left ventricle. The model was driven by compressed air. Its input and output flows were measured as the functions of a pacing rate, driving pressure and artificially introduced mitral regurgitation. These were compared with the corresponding data derived from the ultrasonic measurements that are based on the correlation between echo-contrast agent concentration in the volume of interest and the flow through it. Algorithms for quantitative estimations of forward stroke volume (cardiac output) and mitral regurgitation are given. This study shows, for the first time, both analytically and experimentally, that the pulsating modulation of contrast agent concentration vs. time curves in the ventricle and atrium volumes is closely related to the pulsating nature of the flow in the system. It also shows that the amplitude of the atrium concentration modulation is directly proportional to the maximum value of the incoming (to atrium) flow.

Experimental investigation of the pulse inversion technique for imaging ultrasound contrast agents

The application of ultrasound contrast agents aims to detect low velocity blood flow in the microcirculation. To enhance discrimination between tissue and blood containing the contrast agent, harmonic imaging is used. Harmonic imaging requires the application of narrow-band signals and is obscured by high levels of native harmonics generated in an intervening medium. To improve discrimination between contrast agent and native harmonics, a pulse inversion technique has been proposed. Pulse inversion allows wide-band signals, thus preserving the axial resolution. The present study examines the interference of native harmonics and discusses the practical difficulties of wide-band pulse inversion measurements of harmonics by a single transducer. Native harmonics are not eliminated by pulse inversion. Furthermore, only even harmonics remain and are amplified by 6 dB, alleviating the requirement for selective filtering. Finally, it is shown that the contaminating third harmonic contained in the square wave activation signal leaks through in the emitted signal. The spectral location of the contaminating third harmonic is governed by the transducer spectral characteristics while the location of the native and contrast agent second harmonics is not. Thus the contaminating third harmonic and the native and contrast agent second harmonics may overlap and interfere. Optimal discrimination requires a balance between maximal sensitivity for the second harmonic at reception and minimal interference from the contaminating third harmonic.

Persistent opacification of the left ventricle and myocardium with a new echo contrast agent

Echo contrast agents with long survival times open up new fields of application in the investigation of tissue perfusion and cardiovascular function. The purpose of this study was to characterize the time-course of the opacification of the heart cavities and myocardium with a new long-lasting second-generation, phospholipid-based echo contrast agent containing perfluoropentane (BY963-C5F12), and to compare its contrast potency with that of air-filled phospholipid monolayer (BY963-air). Doses of 0.03 mL/kg, 0.08 mL/kg and 0.16 mL/kg of BY963-air and BY963-C5F12 were administered intravenously to six conscious dogs weighing 25-36 kg. A transthoracic echocardiography was performed to evaluate peak intensity and area under the curve (AUC) from regions-of-interest placed in the right ventricle, left ventricle and left ventricular (LV) myocardium using acoustic densitometry. All injections were well tolerated, without wall-motion abnormalities or ECG changes. The LV cavity and myocardium were uniformly and well opacified for both echo contrast agents. However, at all administered doses, the contrast efficacy and duration were much more pronounced using BY963-C5F12 than with BY963-air. For the myocardium, the average peak intensity increased from 11.9+/-2.8 to 15.0+/-2.7 (not significant) following injection of BY963-air and from 12.8+/-3.2 to 18.7+/-2.8 (p < 0.01) following IV administration of BY963-C5F12; the latter corresponding to an increase in myocardial opacification of 46%. In conclusion, these results show the high myocardial opacification of BY963-C5F12 as compared to BY963-air. The simple incorporation of a perfluorocarbon gas into the phopholipid monolayer BY963 instead of air alters the acoustic properties of this contrast agent, resulting in qualitatively different application potentials for tissue opacification.

Pulse compression for finite amplitude distortion based harmonic imaging using coded waveforms

Finite amplitude distortion based harmonic imaging has been used to reduce the image quality degradation produced by tissue inhomogeneities. Such harmonic signals are significantly lower than the linear components and are possibly too low compared to the dynamic range of the imaging system. To improve signal-to-noise ratio (SNR) without exceeding regulatory limits, coded excitation is explored. In addition, pulse compression schemes suitable for finite amplitude distortion based harmonic imaging are also developed. Note that due to the differences in harmonic generation, these compression schemes are different from those proposed for harmonic imaging using contrast agents. In this paper, simulation examples of SNR improvements by up to 8.2 dB are shown and the efficacy of the compression schemes is studied. Potential sources of performance degradation are also discussed.

A mathematical model for the assessment of hemodynamic parameters using quantitative contrast echocardiography

A mathematical model for the assessment of hemodynamic parameters using quantitative echocardiography is presented. The method involves the intravenous injection of an ultrasonic echo contrast agent. The relative enhancement of the backscattered ultrasound intensity is measured as a function of time (the time-intensity curve). From this measurement, the volume flow rate (cardiac output) and the mixing volume are calculated. Relevant acoustic properties of the ultrasound contrast agent are discussed. An in vitro experiment is performed to corroborate the theory presented.

Methods for quantifying ultrasound backscatter and two-dimensional video intensity: implications for contrast-enhanced sonography

Quantification of acoustic backscatter energy is believed to be useful for assessing "tissue character" and for quantifying the regional concentration of echo contrast. Measurement of ultrasonic video intensity has been the traditional means of quantifying backscatter energy, with "integrated backscatter" considered the gold standard. The purpose of this work is to review the commonly used methods for quantifying ultrasonic backscatter and to describe the difference between detected backscatter energy and the intrinsic tissue backscatter coefficient. Many of the quantification pitfalls that can lead to erroneous conclusions will also be discussed. A set of eight rubber phantoms with backscatter coefficient from -6 dB to +15 dB relative to liver were imaged at 2.5, 3.5, and 5.0 MHz. Methods for calculating the acoustic backscatter intensity from calibrated video intensity measurements and for calculating the tissue backscatter coefficient are described and tested using equipment from two different manufacturers. A commercially available automatic "acoustic densitometry" system with on-board quantitative integrated backscatter is also evaluated. Ultrasound attenuation and ultrasound system factors were found to strongly influence the detected backscatter intensity using either calibrated video intensity or on-board integrated backscatter. Special system transfer functions and attenuation correction were found to be useful in converting video intensity and integrated backscatter to a measure of the intrinsic tissue backscatter coefficient. With these correction factors, the correlation between the measured tissue backscatter coefficient and the phantom backscatter coefficient was excellent (r = 0.99, intercept 0.0, regression slope essentially 1.0) at all three imaging frequencies with traditional video intensity or on-board integrated backscatter. Uncalibrated video intensity and on-board integrated backscatter have limitations when used in isolation for tissue characterization. Rigorous attention to the imaging parameters and the use of calibration functions are necessary before video intensity measurement or integrated backscatter can be used reliably to measure the tissue backscatter coefficient.

Changes in the echoes from ultrasonic contrast agents with imaging parameters

Current harmonic imaging scanners transmit a narrowband signal that limits spatial resolution in order to differentiate the echoes from tissue from the echoes from microbubbles. Because spatial resolution is particularly important in applications, including mapping vessel density in tumors, we explore the use of wideband signals in contrast imaging. It is first demonstrated that microspheres can be destroyed using one or two pulses of ultrasound. Thus, temporal signal processing strategies that use the change in the echo over time can be used to differentiate echoes from bubbles and echoes from tissue. Echo parameters, including intensity and spectral shape for narrowband and wideband transmission, are then evaluated. Through these experiments, the echo intensity received from bubbles after wideband transmission is shown to be at least as large as that for narrowband transmission, and can be larger. In each case, the echo intensity increases in a nonlinear fashion in comparison with the transmitted signal intensity. Although the echo intensity at harmonic multiples of the transmitted wave center frequency can be larger for narrowband insonation, echoes received after wideband insonation demonstrate a broadband spectrum with significant amplitude over a very wide range of frequencies.

Human biodistribution of an ultrasound contrast agent (Quantison) by radiolabelling and gamma scintigraphy

The biodistribution and kinetics of an air filled human serum albumin microcapsule formulation (Quantison) intended for use as an intravenous ultrasound contrast agent have been examined. 12 healthy subjects were administered with approximately 50 million microcapsules per kilogram body weight, radiolabelled with 50 MBq 123I. Imaging was performed over a period of 58 h using a large field-of-view gamma camera and the amount of labelled material present in the blood, urine and faeces measured. Imaging demonstrated that the liver was the organ with the highest uptake, with a mean uptake of 41.8% (SD 10.4%) of the administered dose 1 h following administration. The maximum uptake of the agent in the lungs was low, mean 4.0% (SD 3.4%). A small amount of uptake was visible in the bone marrow; however, this was not quantifiable. There was also evidence of minimal myocardial activity within 5 min of administration. No adverse events were observed and there were no changes in any of the individual post-study indices. The present study demonstrates the safety of Quantison. Gamma scintigraphy played a useful role in confirming the biodistribution of the agent with little lung uptake, high liver uptake and evidence of myocardial uptake.

Stabilized bubbles in the body: pressure-radius relationships and the limits to stabilization

We previously outlined the fundamental principles that govern behavior of stabilized bubbles, such as the microbubbles being put forward as ultrasound contrast agents. Our present goals are to develop the idea that there are limits to the stabilization and to provide a conceptual framework for comparison of bubbles stabilized by different mechanisms. Gases diffuse in or out of stabilized bubbles in a limited and reversible manner in response to changes in the environment, but strong growth influences will cause the bubbles to cross a threshold into uncontrolled growth. Also, bubbles stabilized by mechanical structures will be destroyed if outside influences bring them below a critical small size. The in vivo behavior of different kinds of stabilized bubbles can be compared by using plots of bubble radius as a function of forces that affect diffusion of gases in or out of the bubble. The two ends of the plot are the limits for unstabilized growth and destruction; these and the curve's slope predict the bubble's practical usefulness for ultrasonic imaging or O2 carriage to tissues.

Contrast ultrasonography for 2-D opacification of heart cavities, peripheral vessels, kidney and muscle

Contrast ultrasonography of peripheral vessels and peripheral organs has been only sparsely used to evaluate peripheral tissue blood flow. The purpose of the study was to characterize intraluminal opacification of renal and femoral arteries and veins, of skeletal muscle and renal parenchyma after intraarterial (IA) injection of BY963, a newly developed ultrasound contrast agent being evaluated in Phase II and III trials, and to compare it with opacification of heart cavities after intravenous injection (IV) in dogs. A further purpose was to quantitate possible opacification losses during the first transcapillary passage of BY963 through pulmonary and peripheral microcirculation. BY963 was administered at the dose of 5 mL/animal/vascular territory (0.2 mL/kg). The peak intensity (intensity units = IU) and the area-under-the-curve (AUC, IU x heart cycles) were estimated from regions-of-interest placed in the right ventricle (RV), left ventricle (LV), main renal artery and vein, kidney, femoral artery and vein and adductor muscle. Following single IV injection, the average peak intensity and AUC values were 33 +/- 3 (mean +/- SE) and 674 +/- 109 for the RV, and 27 +/- 2 and 870 +/- 74 for the LV (p < 0.05), respectively. Following single IA injection in the descending aorta, the average peak intensities and AUC values were 35 +/- 2 and 613 +/- 139 in the renal artery and 26 +/- 4 (p < 0.05) and 639 +/- 151 in the renal vein (nonsignificant), respectively. For the femoral vessels, the average peak intensities and AUC values were 30 +/- 3 and 469 +/- 63 in the femoral artery, and 21 +/- 2 (p < 0.05) and 517 +/- 44 in the femoral vein (nonsignificant), respectively. The values for the output-to-input intensity ratios for peak intensity and AUC were 0.82 +/- 0.06 and 1.36 +/- 0.12 for the LV/RV ratio, 0.73 +/- 0.08 and 1.02 +/- 0.05 for the renal vein/renal artery ratio, and 0.71 +/- 0.09 and 1.16 +/- 0.13 for the femoral vein/femoral artery ratio, respectively (nonsignificant). In conclusion, these results demonstrate the high opacification potency of BY963 in the LV, renal and femoral veins, being of the same order of magnitude as that in the RV, renal and femoral arteries, respectively. Finally, the loss of opacification properties of BY963 during the first transcapillary (pulmonary or peripheral-capillary) passage is minimal.

Contrast echocardiography: influence of ultrasonic machine settings, mixing conditions, and pressurization on pixel intensity and microsphere size of Albunex solutions in vitro

To use Albunex as a blood-flow tracer, the stability and consistency of microspheres under mixing conditions must be known. This study examined the effects of mixing conditions and machine settings on the size and echogenicity of Albunex solutions in vitro. Acoustic power, log compression, time-gain compensation, and transducer frequency were varied as Albunex solutions were imaged after mixing with magnetic stirring and pressurized. Higher acoustic power and lower transducer frequency decreased mean pixel intensity of Albunex solution images over time. Intensity, size, and number of Albunex microspheres were not significantly different between stirring speeds. The echogenicity of the Albunex solutions decreased with pressurization, and the critical pressure necessary to reduce the intensity to half its initial value increased with the logarithm of concentration (r = 0.91; p < 0.001). The microsphere size decreased with pressurization and remained smaller after pressure release (3.66 +/- 2.13 versus 1.47 +/- 0.95 microns; p < 0.01). These data indicate that acoustic power and transducer frequency may affect the physical properties of Albunex microspheres, decreasing mean videointensity. Pressure sensitivity of Albunex caused the decrease of videointensity and microsphere size.

Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent

Reliable and reproducible myocardial opacification after intravenous administration of echocardiographic contrast agents has remained elusive. This study was performed to determine whether a new agent, FS069, a suspension of perfluoropropane-filled albumin microspheres (3.6 microns average microbubble size, concentration 8 x 8(8)/ml), could achieve safe and successful myocardial opacification in open-chest dogs. Seventeen dogs (group 1, n = 7, group 2, n = 10) underwent two-dimensional echocardiography before, during, and after the administration of intravenous FS069. Safety was evaluated by measuring arterial and pulmonary artery pressures, heart rate, blood gases, systolic function, myocardial blood flow, and postmortem analysis of myocardial viability by triphenyl-tetrazolium chloride staining. Efficacy to detect changes in regional myocardial perfusion was assessed by injecting FS069 at baseline, after sequential coronary occlusions and reperfusion, and during intravenous vasodilators with and without coronary occlusions. Results were compared with radiolabeled microspheres. FS069 was found to be safe and effective. In the absence of coronary occlusions, uniform myocardial opacification was observed in all dogs. A perfusion defect was observed in all dogs during coronary occlusions. Background-subtracted peak contrast intensity in the myocardium correctly identified regional myocardial blood flow changes and showed a significant correlation with radiolabeled microspheres (r = 0.65, p = 0.0001).

Evidence for a relation between inspired gas mixture and the left ventricular contrast achieved with Albunex in a canine model

BACKGROUND

In a previous experiment, a marked reduction in the right- and left-sided contrast effect of Albunex was noted in an intubated animal spontaneously breathing isoflurane in 100% oxygen. The theory suggests that the time course of echogenicity of microbubbles in liquid is dependent on the pressure and the gradients of dissolved gases. The present set of experiments tested whether the loss of contrast occurs at commonly used therapeutic concentrations of inspired oxygen.

HYPOTHESIS

This research tested the hypothesis that the left ventricular (LV) contrast effect achieved with intravenous injection of the ultrasound contrast agent Albunex is related to the inspired oxygen content.

METHODS

Intubated dogs were maintained in a spontaneously respiring anesthetic state on isoflurane and mixtures of oxygen (12-50%) in nitrogen. FIO2 was held steady for 15 min prior to injection of 0.08 ml/kg of Albunex. The contrast effects were recorded from a transthoracic short-axis view. Left and right ventricular brightness curves were generated from digitized sequences of end-diastolic frames. The minimum and maximum brightness and area under the time-brightness curves were determined.

RESULTS

The LV maximum brightness and area under the curve showed significant negative correlations (p = < 0.004) with the FIO2, while the minimum brightness showed a significant positive correlation (p = < 0.002). No significant correlations were found for the right ventricular brightness parameters.

CONCLUSIONS

These findings show an important relationship between the FIO2 and loss of the contrast effect of Albunex. This loss occurs at oxygen concentrations in the therapeutic range, but could be overcome by increasing the dose of Albunex. The mechanism is likely related to an outward nitrogen gradient causing a loss of echogenicity. The clinical implication is that patients on supplemental oxygen may require higher doses of Albunex to achieve optimal opacification.

Some considerations on the measurements of mean frequency shift and integrated backscatter following administration of Albunex

Ultrasonic contrast agents have been of heightened interest in recent years. More success has been achieved by agents consisting of micro bubbles, since only a few of these agents are capable of producing very strong ultrasonic backscattered signals for the enhancement of certain tissue structures. Recent investigations also demonstrate that an analysis of the radio frequency (RF) backscattered echoes by the contrast agents may lead to quantitative means for assessing tissue perfusion. In these studies, a parameter, mean frequency shift (MFS) of the RF signal, along with integrated backscatter (IB) has received the most attention. In an effort to better understand the physical mechanisms responsible for the observed mean frequency shift, we have performed experiments on 10 dogs following injections of Albunex (Molecular Biosystems, Inc.) into the left atrium, coronary artery and abdominal aorta, respectively, for investigations in the heart and kidney. The integrated backscatter and mean frequency (MF) of a region of interest (ROI) were calculated from the RF signal acquired with a modified real-time ultrasonic scanner. The results show consistently that the RF signals acquired from all regions of interest are greatly affected by the presence of the contrast agent in the path between the transducer and the ROI, which can cause either an upward or a downward shift of the MF. This could not be observed by video densitometry or a measurement of the IB alone. The MFS is the result of the resonant behavior of the micro bubbles, which is related to the frequency, ambient pressure, and physical properties of the bubbles including size distribution, surface tension and concentration. On the other hand, when there is no contrast agent present in the path, a downward frequency shift is seen.

Ultrasonic estimation of tissue perfusion: a stochastic approach

Imaging of blood flow perfusion is an area of significant medical interest. Recently, the advantages of using the total integrated Doppler power spectrum as the parameter that is encoded in color has been shown to result in an approximately threefold increase in flow sensitivity, a relative insensitivity to acquisition angle and lack of aliasing. We have taken this mode a step further and demonstrated the potential for quantifying blood flow using correlation-based algorithms applied to the power signal. We show that phi(tau) = phi(0)e-VT, where phi(tau) is the two-time correlation of the fluctuation in the power signal, and v is the specific flow (reciprocal of mean transit time). Scans of a dog's blood, pumped at a constant rate through gum rubber tubing, were obtained using a Diasonics Spectra 10-MHz linear array transducer at standard range-gated spectral mode (PRF = 1400 Hz, wall filter = 50 Hz, sample gate = 1.5 mm). A fixed Doppler angle of 68 degrees was used. Five different flow rates were tested, and the velocities determined by power decorrelation were compared to the mean velocities calculated from the Doppler shifts by linear regression (R2 = 0.987). We believe the results are very encouraging for using power decorrelation in perfusion evaluation.

When can Doppler be used in place of integrated backscatter as a measure of scattered ultrasound intensity?

The purpose of this work was to determine under what circumstances the intensity of Doppler audio signals can be used as a substitute for the more direct and complex measure of ultrasonic backscatter (integrated backscatter) which requires radio-frequency ultrasound signals. Using a rotating rubber disk phantom and a microbubble echo-contrast flow phantom, we have shown that the intensity of audio Doppler signals is independent of the constraints typically associated with Doppler ultrasound (velocity and angle), but like integrated backscatter depends on the transmit intensity, gain of the ultrasound receiver, attenuation and the nature of the scatterers. Using Doppler ultrasound for backscatter measurements is ideally suited for the expected application of the technique: the assessment of echo contrast in cardiac chambers, blood vessels and tissue perfusion (i.e., any flow system). Compared to integrated backscatter, the Doppler audio method has the advantage of using standard clinical ultrasound machines, requires less sophisticated data storage and processing equipment and the positioning system for the region of interest (the Doppler sample volume) is built into all pulsed-wave Doppler machines. Further, the low-velocity filter removes all nonmoving scatterers (like the intense echoes from heart valves and the walls of blood vessels), thus allowing study of only those echoes originating from the blood pool. This combination of features is what attracted us to the Doppler method for quantitating ultrasonic backscatter in flow systems.